EFFECTIVENESS OF TIOTRIAZOLINE IN COMPLEX THERAPY OF ISCHEMIC HEART DISEASE

EFFECTIVENESS OF TIOTRIAZOLINE IN COMPLEX THERAPY OF ISCHEMIC HEART DISEASE

Aim. To study molecular effects of tiotriazoline in 30 patients with stable angina I-III functional class.Material and methods. Comparison of molecular effects of cardioprotection is done based on dynamics of exercise tolerance dynamics, and via proteomic methods of investigation, questionnaires ass...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. A. Kartashova, A. A. Kastanyan, M. I. Nazheva, A. Yu. Zhulitov, E. I. Zheleznyak
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2016-06-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	tiotriazoline ischemic heart disease exercise tolerance cytochemistry proteomics
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/409
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

NITRATES IN ISCHEMIC HEART DISEASE TREATMENT, YESTERDAY AND TODAY
by: S. N. Tereschenko, et al.
Published: (2015-12-01)

Proceedings of the 17th International Congress of Histochemistry and Cytochemistry, August 27-30, 2025
by: Pavel Hozák, et al.
Published: (2025-08-01)

Biochemistry : the chemical reactions of living cells /
by: Metzler, David E.
Published: (1977)

Long-term effects of enhanced external counterpulsation in the management of patients with ischemic chronic heart failure
by: A. S. Lishuta, et al.
Published: (2024-06-01)

THE POSSIBILITY OF USAGE OF METABOLIC CORRECTION THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE
by: I. V. Sergienko, et al.
Published: (2015-12-01)

ANTIISCHEMIC METABOLIC MODULATOR TRIMETAZIDINE IN TREATMENT OF CORONARY HEART DISEASE
by: V. P. Lupanov
Published: (2017-02-01)

COMORBIDITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE: GENDER DIFFERENCES
by: A. N. Sumin, et al.
Published: (2017-11-01)

Ischemic heart disease and reflux-esophagitis: complexities of the differential diagnosis and treatment.
by: Yu. N. Belenkov, et al.
Published: (2011-05-01)

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015-12-01)

Pharmacoeconomic analysis of heart rate slowing drugs in patients with ischemic heart disease
by: E. I. Tarlovskaya, et al.
Published: (2016-03-01)

EFFECTS OF ENALAPRIL ON ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. I. Katelnizkaya, et al.
Published: (2016-01-01)

MYOCARDIAL REMODELING IN ISCHEMIC HEART DISEASE
by: A. N. Zakirova, et al.
Published: (2016-01-01)

ENDOTHELIAL ADHESIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION
by: A. N. Zakirova, et al.
Published: (2015-09-01)

USE OF AFM FOR MORPHO-FUNCTIONAL STATE DIAGNOSTICS OF PLATELETS OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. V. Kukharenko, et al.
Published: (2019-06-01)

IMMUNO-INFLAMATORY RESPONSE IN ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2015-12-01)

The effect of use simvastatin at treatment of ischemic heart disease patients of senile age
by: A. L. Pirogov, et al.
Published: (2007-10-01)

STENOSIS IN NONCORONARY AREAS AND LIFE QUALITY IN ISCHEMIC HEART DISEASE
by: A. N. Sumin, et al.
Published: (2015-07-01)

ENDOTHELIAL DYSFUNCTION AND “OXIDATIVE STRESS” BY THE NONNSTABLE COURSE OF ISCHEMIC HEART DISEASE
by: A. E. Kratnov, et al.
Published: (2014-07-01)

ASSESSMENT OF ADHERENCE TO TREATMENT AND FACTORS AFFECTING IT IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE DURING THERAPY WITH NICORANDIL
by: S. Yu. Martsevich, et al.
Published: (2017-12-01)

AGOMELATINE IN THE TREATMENT OF ANXIETY AND DEPRESSIVE DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: N. Yu. Shimohina, et al.
Published: (2017-03-01)

A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES
by: Y. A. Karpov
Published: (2015-12-01)

PROTHROMBOTIC POLYMORPHISMS AND LONG-TERM PROGNOSIS OF PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
by: A. L. Komarov, et al.
Published: (2016-01-01)

PROSPECTS FOR CYTOPROTECTORS USE IN THE ELDERLY PATIENTS THROUGH THE EXAMPLE OF CALCIFIED AORTIC STENOSIS AND ISCHEMIC HEART DISEASE
by: N. Yu. Karpova, et al.
Published: (2015-09-01)

RAMIPRIL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE
by: A. I. Chesnikova, et al.
Published: (2016-01-01)

RANOLAZINE IN ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

A case of successful conservative therapy of patient with severe heart failure caused by ischemic heart disease: case report
by: M. T. Beishenkulov, et al.
Published: (2022-05-01)

THE INFLUENCE OF CORONARY BYPASS ON ENDOTHELIAL AND ERECTILE DYSFUNCTION IN ISCHEMIC HEART DISEASE
by: S. A. Pomeshkina, et al.
Published: (2015-01-01)

EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

FEATURES OF MANAGEMENT OF PATIENTS WITH HYPERTENSION IN COMBINATION WITH ISCHEMIC HEART DISEASE: MODERN APPROACHES
by: D. А. Napalkov, et al.
Published: (2017-12-01)

Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease
by: O. A. Rubanenko
Published: (2015-11-01)

Comparative analysis of implantable cardioverter-defibrillator efficacy in ischemic and non-ischemic cardiomyopathy in patients with heart failure
by: Emre Demir, et al.
Published: (2025-07-01)

ISCHEMIC HEART DISEASE AND RENAL DYSFUNCTION
by: F. I. Belyalov
Published: (2017-07-01)

LONG TERM RESULTS OF PERCUTANEOUS CORONARY INTERVENTIONS COMPARING WITH CONSERVATIVE MANAGEMENT IN TREATMENT OF STABLE ISCHEMIC HEART DISEASE PATIENTS UNDER REAL CIRCUMSTANCES
by: V. A. Kuznetsov, et al.
Published: (2016-02-01)

Effectiveness of different treatment regimens of enhanced external counterpulsation in patients with stable coronary artery disease complicated by heart failure
by: A. S. Lishuta, et al.
Published: (2024-03-01)

THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

EFFICACY OF PHYSICAL TRAINING AND ANALYSIS OF LIPID-LOWERING THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER ACUTE CORONARY INCIDENTS
by: D. M. Aronov, et al.
Published: (2016-01-01)

EFFICACY ANALYSIS OF DIFFERENT ANTIANGINAL REGIMENS IN ISCHEMIC HEART DISEASE WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: K. O. Galeeva, et al.
Published: (2015-12-01)

«MEMORIES OF FUTURE»: CHANGE IN VERAPAMIL SIGNIFICANCE IN THE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION
by: S. R. Gilyarevskiy
Published: (2015-09-01)

C-REACTIVE PROTEIN AND ANTIBODIES TO HELICOBACTER PYLORI IN THE PATIENTS WITH ISCHEMIC HEART DISEASE
by: A. Ye. Kratnov, et al.
Published: (2014-07-01)